Hosted on MSN11m
Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ stock dips on earningsOn Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray ... with the use of ketamine products include abuse and misuse, psychiatric events, increases in blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback